March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial ...
Peripheral Artery Disease (PAD)
This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.
March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) t ...
March 6, 2012 — Vascular Magnetics announced it has raised $7 million to advance development of a drug delivery system ...
February 9, 2012 — Boston Scientific announced the United States launch of the TruePath CTO device, designed to ...
January 18, 2012 — Boston Scientific reported nine-month clinical endpoint data from its ORION trial, demonstrating ...
January 13, 2012 — Amorcyte Inc.,a NeoStem Inc. company, announced the expansion of intellectual property protection ...
December 22, 2011 – Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe ...
December 13, 2011 – Boston Scientific announced the U.S. launch of its Charger PTA Balloon Catheter, a 0.035-inch ...
November 23, 2011 – Vascular occlusions are blocked blood vessels caused by a blood clot in an artery. Blocks in the ...
November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post ...
November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent ...
November 4, 2011 — Medtronic Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant ...
November 1, 2011 – Boston Scientific released the schedule of its major events and product-related clinical research for ...
October 17, 2011 — The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has become the first cardiac care ...
October 14, 2011 – A U.S. Food and Drug Administration (FDA) review panel gave its unanimous recommendation for the ...
March 09, 2012